Other approaches have entailed limiting the renal clearance of GLP-1- or exendin-based compounds by covalent fusion of the peptide to a large, stable plasma protein like albumin (albiglutide) (51) or the Fc domain of IgG (dulaglutide) (52)
GLP-1 Agonists Show Promise in Treating Substance Use Disorders Nov 7, 2025 5 min read Updated: Dec 17, 2025 In recent years, medications originally developed to treat Type 2 diabetes, obesity, and other weight-related conditionssuch as semaglutide and liraglutideare showing promise in treating substance use disorders (SUDs)
The FDAs stated concerns are: (1) theoretical risk of allergic reactions with repeated peptide administration, (2) quality control concerns about compounding purity and consistency, and (3) no Phase 1-3 trials conducted under FDA oversight
I have some friends that are doing it and I've heard some not so great things about it, so I was like, I do not want to feel that way
It is an estimate, not a blood level or dosing advice
Benefits of Peptide Therapy Peptides offer a diverse range of benefits depending on your selected treatment plan
